87 related articles for article (PubMed ID: 31077425)
21. Multiple microRNAs regulate tacrolimus metabolism through CYP3A5.
Gu XQ; Tang D; Wan P; Qin T; Yang TH; Wu J; Ji H; Liu JC; Xue F; Tang YJ; Xia Q
Pharmacol Res; 2021 Feb; 164():105382. PubMed ID: 33348024
[TBL] [Abstract][Full Text] [Related]
22. The Clinical Impact of the C
van Gelder T; Meziyerh S; Swen JJ; de Vries APJ; Moes DJAR
Front Pharmacol; 2020; 11():1142. PubMed ID: 32848756
[TBL] [Abstract][Full Text] [Related]
23. Effects of donor-recipient combinational CYP3A5 genotypes on tacrolimus dosing in Chinese DDLT adult recipients.
Liu J; Chen D; Yao B; Guan G; Liu C; Jin X; Wang X; Liu P; Sun Y; Zang Y
Int Immunopharmacol; 2020 Mar; 80():106188. PubMed ID: 31931373
[TBL] [Abstract][Full Text] [Related]
24. Association Between CYP3A5 Genetic Polymorphisms with Tacrolimus Dose Requirement and Allograft Outcomes in Iranian Kidney Transplant Recipients.
Ghafari S; Dashti-Khavidaki S; Khatami MR; Ghahremani MH; Seyednejad SA; Beh-Pajooh A
Iran J Kidney Dis; 2019 Nov; 13(6):414-416. PubMed ID: 31880588
[TBL] [Abstract][Full Text] [Related]
25. Cost-effectiveness analysis of CYP3A5 genotype-guided tacrolimus dosing in solid organ transplantation using real-world data.
Deininger KM; Anderson HD; Patrinos GP; Mitropoulou C; Aquilante CL
Pharmacogenomics J; 2024 May; 24(3):14. PubMed ID: 38750044
[TBL] [Abstract][Full Text] [Related]
26. A systematic review and meta-analysis recite the efficacy of Tacrolimus treatment in renal transplant patients in association with genetic variants of
Chauhan PM; Hemani RJ; Solanki ND; Shete NB; Gang SD; Konnur AM; Srivastava R; Pandey SN
Am J Clin Exp Urol; 2023; 11(4):275-292. PubMed ID: 37645617
[TBL] [Abstract][Full Text] [Related]
27. Higher number of tacrolimus dose adjustments in kidney transplant recipients who are extensive and intermediate CYP3A5 metabolizers.
Reininger KA; Onyeaghala G; Anderson-Haag T; Schladt DS; Wu B; Guan W; Dorr CR; Remmel RP; Mannon R; Matas AJ; Oetting WS; Stahler P; Israni AK; Jacobson PA
Clin Transplant; 2023 Apr; 37(4):e14893. PubMed ID: 36571802
[TBL] [Abstract][Full Text] [Related]
28. Tacrolimus Concentration Is Effectively Predicted Using Combined Clinical and Genetic Factors in the Perioperative Period of Kidney Transplantation and Associated with Acute Rejection.
Cheng F; Li Q; Cui Z; Wang Z; Zeng F; Zhang Y
J Immunol Res; 2022; 2022():3129389. PubMed ID: 36118414
[TBL] [Abstract][Full Text] [Related]
29. Use of Pharmacogenetics to Optimize Immunosuppressant Therapy in Kidney-Transplanted Patients.
Urzì Brancati V; Scarpignato C; Minutoli L; Pallio G
Biomedicines; 2022 Jul; 10(8):. PubMed ID: 35892699
[TBL] [Abstract][Full Text] [Related]
30. Efficacy and Outcomes of CYP3A5 Genotype-Based Tacrolimus Dosing Compared to Conventional Body Weight-based Dosing in Living Donor Kidney Transplant Recipients.
Raj TY; Fernando ME; Srinivasa Prasad ND; Sujit S; Valavan KT; Harshavardhan TS; Ramanathan A
Indian J Nephrol; 2022; 32(3):240-246. PubMed ID: 35814319
[TBL] [Abstract][Full Text] [Related]
31. Efficacy and Safety of Tacrolimus-Based Maintenance Regimens in De Novo Kidney Transplant Recipients: A Systematic Review and Network Meta-Analysis of Randomized Controlled Trials.
T A M; Chng R; Yau WP
Ann Transplant; 2021 Dec; 26():e933588. PubMed ID: 34963678
[TBL] [Abstract][Full Text] [Related]
32. Genetic Polymorphisms Affecting Tacrolimus Metabolism and the Relationship to Post-Transplant Outcomes in Kidney Transplant Recipients.
Cheng F; Li Q; Wang J; Hu M; Zeng F; Wang Z; Zhang Y
Pharmgenomics Pers Med; 2021; 14():1463-1474. PubMed ID: 34824543
[TBL] [Abstract][Full Text] [Related]
33. Clinical Implications of Tacrolimus Time in Therapeutic Range and Intrapatient Variability in Urban Renal Transplant Recipients Undergoing Early Corticosteroid Withdrawal.
Pierce DR; West-Thielke P; Hajjiri Z; Gaitonde S; Tzvetanov I; Benedetti E; Lichvar AB
Transplant Direct; 2021 Jun; 7(6):e698. PubMed ID: 34036168
[TBL] [Abstract][Full Text] [Related]
34. Tacrolimus trough levels higher than 6 ng/mL might not be required after a year in stable kidney transplant recipients.
Jung HY; Seo MY; Jeon Y; Huh KH; Park JB; Jung CW; Lee S; Han SY; Ro H; Yang J; Ahn C; Choi JY; Cho JH; Park SH; Kim YL; Kim CD
PLoS One; 2020; 15(7):e0235418. PubMed ID: 32614859
[TBL] [Abstract][Full Text] [Related]
35. Therapeutic concentration achievement and allograft survival comparing usage of conventional tacrolimus doses and CYP3A5 genotype-guided doses in renal transplantation patients.
Anutrakulchai S; Pongskul C; Kritmetapak K; Limwattananon C; Vannaprasaht S
Br J Clin Pharmacol; 2019 Sep; 85(9):1964-1973. PubMed ID: 31077425
[TBL] [Abstract][Full Text] [Related]
36. Impact of the CYP3A5 genotype on the distributions of dose-adjusted trough concentrations and incidence of rejection in Japanese renal transplant recipients receiving different tacrolimus formulations.
Niioka T; Kagaya H; Saito M; Inoue T; Numakura K; Yamamoto R; Habuchi T; Satoh S; Miura M
Clin Exp Nephrol; 2017 Oct; 21(5):787-796. PubMed ID: 28271256
[TBL] [Abstract][Full Text] [Related]
37. The TOMATO Study (Tacrolimus Metabolization in Kidney Transplantation): Impact of the Concentration-Dose Ratio on Death-censored Graft Survival.
Jouve T; Fonrose X; Noble J; Janbon B; Fiard G; Malvezzi P; Stanke-Labesque F; Rostaing L
Transplantation; 2020 Jun; 104(6):1263-1271. PubMed ID: 31415035
[TBL] [Abstract][Full Text] [Related]
38. Polymorphism of the CYP3A5 gene and its effect on tacrolimus blood level.
Nair SS; Sarasamma S; Gracious N; George J; Anish TS; Radhakrishnan R
Exp Clin Transplant; 2015 Apr; 13 Suppl 1():197-200. PubMed ID: 25894154
[TBL] [Abstract][Full Text] [Related]
39. Pharmacogenetic considerations for optimizing tacrolimus dosing in liver and kidney transplant patients.
Provenzani A; Santeusanio A; Mathis E; Notarbartolo M; Labbozzetta M; Poma P; Provenzani A; Polidori C; Vizzini G; Polidori P; D'Alessandro N
World J Gastroenterol; 2013 Dec; 19(48):9156-73. PubMed ID: 24409044
[TBL] [Abstract][Full Text] [Related]
40. Clinical aspects of tacrolimus use in paediatric renal transplant recipients.
Prytuła A; van Gelder T
Pediatr Nephrol; 2019 Jan; 34(1):31-43. PubMed ID: 29479631
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
